LET’S END THIS TOGETHER

HOW CAN YOUR CLIA LAB PLAY A ROLE?

Using the appropriate SARS-CoV-2 PCR test authorized for emergency use by the U.S. FDA, your lab can easily pivot from diagnostics, to screening asymptomatic individuals. PerkinElmer can help you get there by immediate deployment of solutions you need.

LOD matters. A highly sensitive RT-PCR test should be used for screening asymptomatic individuals

According to the FDA companion resource, a highly sensitive RT-PCR test should be used for screening asymptomatic individuals without known exposure to SARS-CoV-21. The PerkinElmer New Coronavirus Nucleic Acid Detection Kit is the most sensitive commercially available COVID-19 molecular diagnostic test authorized for emergency use, as reported by FDA’s reference panel study2.

PerkinElmer, Inc. is one of a few entities that manufactures a molecular diagnostic test kit authorized by the FDA to screen pooled asymptomatic individuals4 – this capability is at the very heart of a successful COVID-19 testing program for K-12 school1.

Kits authorized by the FDA to screen pooled asymptomatic individuals
Pooling reduces costs for screening K-12 students

PerkinElmer’s OneSource® Laboratory Services organization and field application specialist teams have been instrumental in enabling labs to significantly scale up daily testing capacity in a matter of days to screen school children and other communities. PerkinElmer has a strong, vertically integrated supply chain that encompasses the development and manufacture of critical components such as viral nucleic acid extraction, RT-PCR, automation equipment, plastics and consumables enabling cost-effective, reliable, and single-source solutions for SARS-CoV-2 screening, surveillance, and diagnosis.

References:

  1. FDA. A Closer Look at Coronavirus Disease 2019 (COVID-19) Diagnostic Testing
  2. Lowest limit of detection, and most sensitive reflect a comparison of analytical sensitivity between Emergency Use Authorized COVID test kits as reported in FDA SARS-CoV-2 Reference Panel on October 7, 2021.
  3. FDA. In Vitro Diagnostics EUAs. April, 14, 2021.
Contact your PerkinElmer representative today to ensure that your lab is ready for screening K-12 students!

For emergency use authorization only. Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.